Top Drug Development Stories


Comment & Analysis »

GlobalData Healthcare

Roche’s Tecentriq pulls further ahead in metastatic bladder cancer

Roche’s Tecentriq was approved in May 2016 for the second-line treatment of locally advanced/metastatic urothelial cancer following prior failure on platinum-based doublet chemotherapy....

Roche’s Tecentriq pulls further ahead in metastatic bladder cancer
Chris Lo

Pharma payments to doctors: seeking transparency

Pharma payments to doctors: seeking transparency
 

How does the NHS weigh the costs of HIV preventing drugs?

How does the NHS weigh the costs of HIV preventing drugs?
Elly Earls

India's drug price overhaul: a question of balance

India's drug price overhaul: a question of balance
 

Pay-for-delay: how far will companies go to protect market exclusivity?

Pay-for-delay: how far will companies go to protect market exclusivity?

Company Releases »

Introducing Morphologically Directed Raman Spectroscopy

Malvern Instruments
Introducing Morphologically Directed Raman Spectroscopy

Top Five Ways to Use Zetasizer Nano to Improve Stability of Your Formulation

Malvern Instruments Top Five Ways to Use Zetasizer Nano to Improve Stability of Your Formulation

11 Key Things to Consider When Buying an Advanced Gel Permeation Chromatography or Size Exclusion Chromatography System

Malvern Instruments
11 Key Things to Consider When Buying an Advanced Gel Permeation Chromatography or Size Exclusion Chromatography System

Extending Rheological Measurements Using Squeeze Flow

Malvern Instruments Extending Rheological Measurements Using Squeeze Flow

Drug Development Insights »

Companies »